The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail vetinfo@hpra.ie


BRONCHI-SHIELD, lyophilisate and solvent for suspension for nasal drops for dogs

2.1x 10^6 - 5.5 x 10^ 8 colony forming unit(s)/millilitre Lyophilisate and solvent for nasal drops, suspension

Zoetis Belgium S.A.VPA10387/004/001

Main Information

Trade NameBRONCHI-SHIELD, lyophilisate and solvent for suspension for nasal drops for dogs
Active SubstancesBordetella bronchiseptica, live, attenuated strain 92b
Strength2.1x 10^6 - 5.5 x 10^ 8 colony forming unit(s)/millilitre
Dosage FormLyophilisate and solvent for nasal drops, suspension
Licence HolderZoetis Belgium S.A.
Licence NumberVPA10387/004/001

Group Information

ATC CodeQI07AE01 bordetella
Therapeutic ClassImmunological - Live Vaccine
SpeciesDogs

Status

Authorised/WithdrawnAuthorised
Licence Issued29/11/2013
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back